# Safety Study of LY3041658 in Healthy Participants

> **NCT02148627** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 54 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3041658 (SC)
- **DRUG:** LY3041658 (IV)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02148627
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06-16
- **Primary completion:** 2017-02-11
- **Final completion:** 2017-02-11
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2017-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02148627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02148627, "Safety Study of LY3041658 in Healthy Participants". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02148627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*